Table of contents 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. Global Blood Plasma Market: Product Outlook 5. Global Blood Plasma Market: Growth and Forecast 5.1 By Value (2013-2017) 5.2 By Value (2018-2023) 5.3 By Company Share (2017) 6. Global Blood Plasma Market Size, By Type: Breakdown (%) 6.1 Global Immunoglobulins (IV+SC) Market 6.1.1 By Value (2013-2023) 6.1.2 By Volume (2013-2023) 6.1.3 By Company Share, 2017 6.2 Global Albumin Market 6.2.1By Value (2013-2023) 6.2.2 By Volume (2013-2023) 6.2.3 By Company Share, 2017 6.3 Global FVIII (pd) Market 6.3.1 By Value (2013-2023) 6.3.2 By Volume (2013-2023) 6.3.3 By Company Share, 2017 6.4 Global Other Plasma Product Market: By Value (2013-2023) 6.5 Global Blood Plasma Market: Market Comparison, By Segments 6.6 Global Blood Plasma Market: Market Attractiveness, By Segments 7. Global Blood Plasma Market: Regional Analysis 7.1 North America Blood Plasma Market: An Analysis 7.1.1 By Value (2013-2017) 7.1.2 By Value (2018-2023) 7.2 North America Blood Plasma Market: Country Analysis 7.2.1 U.S.A Blood Plasma Market, By Value (2013-2023) 7.2.2 Canada Blood Plasma Market, By Value (2013-2023) 7.3 Europe Blood Plasma Market: An Analysis 7.3.1 By Value (2013-2017) 7.3.2 By Value (2018-2023) 7.4 Europe Blood Plasma Market: Country Analysis 7.4.1 Germany Blood Plasma Market, By Value (2013-2023) 7.4.2 France Blood Plasma Market, By Value (2013-2023) 7.4.3 Italy Blood Plasma Market, By Value (2013-2023) 7.5 APAC Blood Plasma Market: An Analysis 7.5.1 China Blood Plasma Market, By Value (2013-2023) 7.5.2 Japan Blood Plasma Market, By Value (2013-2023) 7.5.3 India Blood Plasma Market, By Value (2013-2023) 7.5.4 Australia Blood Plasma Market, By Value (2013-2023) 7.5.5 South-East Asia Blood Plasma Market, By Value (2013-2023) 7.6 ROW Blood Plasma Market: An Analysis 7.6.1 By Value (2013-2017) 7.6.2 By Value (2013-2023) 7.7 Global Blood Plasma Market: Market Comparison, By Regions 7.8 Global Blood Plasma Market: Market Attractiveness, By Regions 8. Global Blood Plasma Market Dynamics 8.1 Drivers 8.2 Challenges 8.3 Trends 9. Blood Plasma Market: Policy and Regulatory Landscape 10. Global Blood Plasma Market: Supply Chain Analysis 11. Porter's Five Forces Analysis 12 Company Profiles 12.1 CSL Limited 12.2 Baxter International 12.3 Grifols S.A. 12.4 Octa Pharma 12.5 Emergent Bio-solutions 12.6 Antaris Pharma 12.7 AMAG Pharma 12.8 Kedrion Biota Pharma 12.9 Bio delivery Science International 12.10 Biotest A.G.

List of Figures Figure 1: Plasma Proteins and Diseases They Treat Figure 2: Global Blood Plasma Market Size, By Value, 2013-2017 (USD Billion) Figure 3: IVIG Consumption, By Selected Countries, 2015, (Kg/million population) Figure 4: Endocrine, Metabolic, Blood and Immune Disorders, DALYs Per Million, Both Sexes, All ages, 2016 Figure 5: United States Blood Plasma Collection, 2013-2016, in Million Liters Figure 6: Number of Blood Collection Centers in United States, 2013-2016 Figure 7: United States Healthcare Expenditure, 2013-2016 Figure 8: United States Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram) Figure 9: United Blood States Plasma Export to World, 2013-2016, By Value (In Billion) Figure 10: China Blood Plasma Export to World, 2013-2016, By Volume (In Kilogram) Figure 11: Worldwide Demand for factor VIII, By Volume (in IU) Figure 12: Number of People With Bleeding Disorders, Worldwide, By Specific Disease, 2016 Figure 13: Number of People With Hemophilia, Worldwide, By Type, 2016 Figure 14: Usage of Factor VIII (IU Per Capita)*, 2016 Figure 15: Usage of Factor IX Per Capita (IU Per Capita)#, 2016 Figure 16: Number of People With Hemophilia, By Top 5 Countries, 2016 Figure 17: Number of Plasma Fractionation Plants, 2014 Figure 18: Capacity and Throughput of The Largest Fractionators ( In Thousand Liters) Figure 19: Number of Prevalent Cases of COPD, Worldwide, 2015, (in thousands) Figure 20: Number of Deaths By Alzheimer's Diseases and Other Dementias, By Selected Countries, 2016, (Per Million of Population) Figure 21: Global Aged Population (Above 65), 2013-2017 (% of total) Figure 22: Global Aged Population (Above 65), By Country, 2017 (% of total) Figure 23: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) Figure 24: Global Expected Healthcare Industry Outlook Figure 25: Regional Expected Healthcare Industry Growth Rate By Year 2020 Figure 26: Key Factors Driving Global Healthcare Industry Figure 27: Global Blood Plasma Market Size, By Value, Forecast, 2018-2023 (USD Billion) Figure 28: Global Blood Plasma Market Share, By Company, 2017 Figure 29: Global Blood Plasma Market Size, By Type, 2017 (%) Figure 30: Global Blood Plasma Market Size, By Type, 2023F (%) Figure 31: Global Immunoglobulins Market, By Value, 2013-2017 (USD Billion) Figure 32: Global Immunoglobulins Market, By Value,2018-2023(USD Billion) Figure 33: Global Immunoglobulin Market, By Volume, 2013-2017, Volume (Tons) Figure 34: Global Immunoglobulins Market, By Volume, 2018-2023(Tons) Figure 35: Global IVIG Market Share, By Company, 2017 Figure 36: Global Albumin Market, By Value, 2013-2017 (USD Billion) Figure 37: Global Albumin Market, By Value, 2018-2023 (USD Billion) Figure 38: Global Albumin Market, By Volume, 2013-2017 (Tons) Figure 39: Global Albumin Market, By Volume, 2018- 2023 (Tons) Figure 40: Global Albumin Market Share, By Company, 2017 Figure 41: Global Factor VIII (Plasmatic), By Value, 2013-2017 (USD Billion) Figure 42: Global Factor VIII (Plasmatic), By Value, 2018-2023 (USD Billion) Figure 43: Global Factor VIII Market, By Volume, 2013-2017 (International Units) Figure 44: Global Factor VIII Market, By Volume, 2018-2023 (International Units) Figure 45: Global FVIII (Pd) Market Share, By Company, 2017 Figure 46: Other Plasma Products Market, By Value, 2013-2017 (USD Billion) Figure 47: Other Plasma Products Market, By Value, 2018-2023 (USD Billion) Figure 48: Market Comparison Chart, By Segments, 2013-2023 (USD Billion) Figure 49: Global Market Attractiveness, By Segments, 2023F Figure 50: Healthcare Industry Landscape, By Selected Region Figure 51: North America Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 52: North America GDP per capita, current prices, 2013-2023F (In USD) Figure 53: North America population aged 65 and above, 2013-2017 (% of total) Figure 54: United States health care expenditure per capita,2013-2016(USD) Figure 55: Canada health care expenditure per capita,2013-2016(USD) Figure 56: North America Blood Plasma Market, By Value, 2018-2023 (USD Billion) Figure 57: USA Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 58: USA Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 59: U.S., Population ages 65 and above, 2013-2017 (% of total) Figure 60: U.S. Blood Plasma Export To The World, 2015-2016, By Volume (In Kg) Figure 61: United States health care expenditure,2013-2017(% of GDP) Figure 62: Canada Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 63: Canada Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 64: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %) Figure 65: Canada, Population ages 65 and above, 2012-2017 (% of total) Figure 66: Europe Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 67: Health Expenditure, By Select Country, 2016 (% of GDP) Figure 68: Europe Population ages 65 years and above (% of total population), 2013-17 Figure 69: European Country Population Aged 65 and Above, 2012-2017 (% of Total) Figure 70: GDP, Europe Region, By Select Country, 2017 (In Trillion USD) Figure 71: Europe Blood Plasma Market, By Value, 2018-2023 (USD Billion) Figure 72: Germany Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 73: Germany Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 74: Germany, Population ages 65 and above, 2012-2017 (% total) Figure 75: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD) Figure 76: France Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 77: France Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 78: France, Population Ages 65 and Above, In total Population, 2013-2017 Figure 79: Italy Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 80: Italy Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 81: Italy, Population Ages 65 and Above (% of total), 2013-2017 Figure 82: APAC & Oceania Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 83: GDP Per Capita in APAC, By Selected Country, 2013 (In USD) Figure 84: GDP Per Capita in APAC, By Select Country, 2016 (In USD) Figure 85: Population ages 65 and above, By Select Country, 2017 (% of total) Figure 86: Population ages 65 and above, By Select Country, 2050 (% of total) Figure 87: APAC & Oceania Blood Plasma Market, By Value, 2018-2023 (USD Billion) Figure 88: China Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 89: China Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 90: China, Total Population, 2013-17 (In Billion) Figure 91: China, GDP Growth Per Year, 2015-2019F (In %) Figure 92: China, Share of Urban Population, 2012-2017 (In %) Figure 93: China, Share of Urban Population, 2012-2017 (In %) Figure 94: Japan Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 95: Japan Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 96: Japan, Consumption of IVIG, 2013-2017, (Million Vails/2.5g) Figure 97: Plasma (Domestic Plasma) Through output by Japanese Fractionators, 2013-2017, Million Liters Figure 98: Japan, Population ages 65 and above, 2012-2017 (% of total) Figure 99: Japan Healthcare Expenditure Outlook (%) Figure 100: India Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 101: India Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 102: India, Population ages 65 and above, 2013-2017 Figure 103: India, Share of Urban Population, 2012-2017 (In %) Figure 104: India, GDP Growth Per Year, 2015-2019 (In %) Figure 105: India, Total Population, 2013-2023F (In Billion) Figure 106: India, Health Expenditure Per Capita, PPP, 2012-2017 (USD) Figure 107: India, Population ages 65 and above, 2012-2017 (% total) Figure 108: Australia Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 109: Australia Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 110: Australia, IG Demand, 2013- 2016 (Thousand Gram) Figure 111: Australia, Source Plasma Collection Growth, 2013-2016 (%) Figure 112: Australia, Population Above 65, 2013-2017 (% of Total) Figure 113: Australia, Healthcare Expenditure, 2013- 2017 (% of GDP) Figure 114: South-East Asia Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 115: South-East Asia Blood Plasma Market, By Value, 2018-2023(USD Billion) Figure 116: Population Above 65, By Selected Southeast Asian Countries, 2017 (% of Total) Figure 117: Healthcare Expenditure, By Selected Southeast Asian Countries, 2015 (% of GDP) Figure 118: ROW Blood Plasma Market, By Value, 2013-2017 (USD Billion) Figure 119: GDP Per Capita in ROW, By Select Country, 2013 (In USD) Figure 120: GDP Per Capita in ROW, By Select Country, 2017 (In USD) Figure 121: Population ages 65 and above, By Select Country, 2017 (% of total) Figure 122: Population ages 60 or above, By Select Country, 2050 (% of total) Figure 123: Latin America and Caribbean, Population ages 65 and above 2012-2017(% of total) Figure 124: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %) Figure 125: Middle East and North Africa, Population ages 65 and above (% of total) Figure 126: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion) Figure 127: ROW Blood Plasma Market, By Value, 2018-2023 (USD Billion) Figure 128: Regional Market Comparison Chart, 2013-2023 (USD Billion) Figure 129: Global Market Attractiveness, By Region, 2023F Figure 130: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %) Figure 131: Global Aged Population(Above 65), (% of total) Figure 132: Male population, 2013-2017 (In Billion) Figure 133: Number of People With Dementia (In Million) Figure 134: Grifols Plasma Fractionation Capacity Growth (In Million Litters) Figure 135: CSL Limited Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 136: CSL Limited, Sales, By Business Segments, 2017 (In %) Figure 137: CSL Limited, By Geographic Region, 2017 (In %) Figure 138: Baxter International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 139: Baxter International, By Business Segments, 2017 (In %) Figure 140: Baxter International, By Geographic Region, 2017 (In %) Figure 141: Grifols S.A, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 142: Grifols S.A, By Business Segments, 2017 (In %) Figure 143: OCTA Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 144: Emergent Bio-Solutions, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 145: Emergent Bio-Solutions, By Geography, 2017 (In %) Figure 146: Antaris Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 147: AMAG Pharma, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 148: Kedrion Bio Pharma, Sales Revenue, 2013-2017 (USD Billion) Figure 149: Kedrion Bio Pharma, Sales Revenue, By Geography, 2017 (%) Figure 150: Bio Delivery Science International, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 151: Biotest A.G, Sales Revenue, Sales Revenue, 2013-2017 (USD Billion) Figure 152: Biotest A.G, By Geography, 2017 (In %)

CSL Limited, Baxter International, Grifols S.A, Octa Pharma, Emergent Bio-solutions, Antaris Pharma, AMAG Pharma, Biota Pharma, Bio delivery Science International, Biotest A.G.